Benign Paroxysmal Positional Vertigo (BPPV) Clinical Trial
Official title:
Comparison of the Treatment Outcomes of Posterior Canal Benign Paroxysmal Positional Vertigo (BPPV) With Canalith Repositioning Procedure (CRP): Single Versus Multiple Cycles
Unilateral posterior canal benign paroxysmal positional vertigo (BPPV) cases will be randomized to treat with single or multiple cycles of canalith repositioning procedure.The treatment outcomes will be assessed at 7th and 28th days.
Patients present with brief episodes of vertigo will be evaluated by Dix-Hallpike test. Cases with positive Dix-Hallpike test, unilateral, posterior canal, will be randomized with block of four. Either single or multiple cycles of canalith repositioning procedure will be performed. Four treatment outcomes will be blindly assessed at 7 and 28 days. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT01822002 -
Treatment of Posterior Canal Type of Benign Paroxysmal Positional Vertigo
|
N/A | |
Completed |
NCT04849182 -
Vertistop® D and Vertistop® L in Preventing Recurrence of High-recurrence BPPV
|
N/A | |
Recruiting |
NCT04935970 -
Metabolic Disorders and Vertigo
|
||
Recruiting |
NCT05984901 -
The CAVA Multicentre Dizziness Trial
|
N/A |